ArticleRheumatology international2026

Long-term safety and pulmonary function stabilization with nintedanib in systemic sclerosis-associated interstitial lung disease, 2020-2025: a real-world retrospective study from a reference centre.

Stylianos Panopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.